Pharmaceuticals
10 advertising and promotion regulatory review experts
These ten professionals have led regulatory review of advertising and promotion in their own roles at pharmaceutical and biotech companies. A reader can learn how drug companies review promotional materials against FDA advertising and promotion rules.
Professionals to explore
01—10Alexander T. Zachos, J.D.
LinkedInExperience: Senior Director, US Regulatory Advertising & Promotion · Takeda
Former Senior Director, US Regulatory Advertising & Promotion at Takeda (2018–2026) and Executive Director, Regulatory Advertising & Promotion at Boehringer Ingelheim since 2026. The profile describes leading Regulatory A&P teams and lists Senior Manager of Regulatory Affairs, Labeling & Advertising at Intercept Pharmaceuticals (2015–2018).
Angela Muñoz
LinkedInExperience: Director, Regulatory Advertising & Promotion · Novo Nordisk
Director, Regulatory Advertising & Promotion at Novo Nordisk since 2023 and former Associate Director, Regulatory Advertising & Promotion there (2018–2023). The profile also lists Sr. Manager, Regulatory Affairs, Therapeutic Area and Promotional Review at Novo Nordisk (2015–2017) and describes developing risk assessment and mitigation plans cross-functionally.
Cindy Jou Meyers, MBA, RAC
LinkedInExperience: Senior Director, Regulatory Advertising and Promotion · Verastem Oncology
Senior Director, Regulatory Advertising and Promotion at Verastem Oncology since 2024. Former Executive Director, Regulatory Affairs, Advertising & Promotions at Oyster Point Pharma (2021–2024), Director, Regulatory Advertising and Promotion at bluebird bio (2019–2021) and Director, Promotional Regulatory Affairs at Shire (2015–2019).
Edward Han, PharmD, RPh
LinkedInExperience: Director, Advertising and Promotion Regulatory Affairs · Bayer
Former Director, Advertising and Promotion Regulatory Affairs at Bayer (2021–2025), where the profile says the role conducted review and assessment of US promotional, disease awareness, public affairs and medical materials. Senior Director, Regulatory Affairs - Ad Promo Labeling at Lantheus since 2025; the profile also lists Manager. US Regulatory Advertising & Promotion at Takeda (2019–2020).
Kevin Stark
LinkedInExperience: Vice President Promotion Advertising and Regulatory Affairs · Madrigal Pharmaceuticals
Vice President Promotion Advertising and Regulatory Affairs at Madrigal Pharmaceuticals since 2026. Former Global Head of Ad Promo and Labeling at Mallinckrodt Pharmaceuticals (2024–2025), Executive Director, Advertising Promotion Review at Organon (2021–2024) and Director Team Leader, Office of Promotion and Advertising Review at Merck (2015–2021).
Marybeth Toscano, PharmD, RPh, RAC
LinkedInExperience: Director, Advertising and Promotion Compliance, Rare Disease, Neurology · Alexion Pharmaceuticals, Inc.
Former Director, Advertising and Promotion Compliance, Rare Disease, Neurology at Alexion Pharmaceuticals, Inc. (2021–2025) and Director, Regulatory Advertising & Promotion at Sumitomo Pharma America, Inc. since 2026. The profile also lists Regulatory Review Officer, Oncology at FDA (2011–2015) and describes over 14 years of regulatory advertising and promotion experience in industry and at the FDA office known as OPDP.
Robert Nguyen, PharmD
LinkedInExperience: Director, US Regulatory Advertising and Promotion · Pfizer
Director, US Regulatory Advertising and Promotion at Pfizer since 2023. Former Director, Regulatory Advertising and Promotion (2023) and Associate Director, Regulatory Advertising and Promotion (2021–2023) at Seagen, and Regulatory Review Officer (OPDP) at FDA (2017–2021).
Sharon Watson, PharmD, MSPharm, MBA
LinkedInExperience: Director Promotional Regulatory Affairs · AstraZeneca
Director Promotional Regulatory Affairs at AstraZeneca since 2020 and former Associate Director Promotional Regulatory Affairs there (2015–2020). The profile describes the director role as covering oncology, and its headline lists oncology launches, FDA accelerated approvals, drug regulatory affairs and alliances.
Sheila Kundu
LinkedInExperience: Director, Regulatory Affairs Advertising & Promotion · Gilead Sciences
Director, Regulatory Affairs Advertising & Promotion at Gilead Sciences since 2022 and former Associate Director, Regulatory Affairs Advertising & Promotion there (2019–2022). The profile also lists Senior Manager - US Regulatory Advertising and Promotion at Biogen (2017–2019) and describes applying FDA advertising and promotion regulations and guidances.
Sigita Burke
LinkedInExperience: Director, Regulatory Advertising & Promotion · Genmab
Director, Regulatory Advertising & Promotion at Genmab since 2024. Former Director, Regulatory Advertising and Promotion - Oncology (2022–2024) and Associate Director, Regulatory Affairs, Ad Promo, Oncology (2019–2022) at Johnson & Johnson, and Associate Director, Promotional Regulatory Review at Teva Pharmaceuticals (2018–2019).
Choose the right perspective
Match the person's company stage to yours, since setting up promotional review for a first launch differs from running it across a large marketed portfolio. Also consider whether the person's background includes FDA review experience, launch work or disease awareness campaigns, and ask which of these matches your question.
Questions to take into the conversation
- 01How do you structure the promotional review committee so materials get approved quickly without cutting corners?
- 02What claims or presentations most often draw FDA attention, and how do you advise brand teams on them?
- 03How do you prepare launch materials for FDA advisory review, and what do you do with the comments you get back?
Reaching advertising and promotion regulatory review experts
How can I contact one of these advertising and promotion regulatory review experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 10 companies, including Takeda, Novo Nordisk and Verastem Oncology, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach advertising and promotion regulatory review experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal